{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T15:04:59Z","timestamp":1772204699297,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Xi'an Science and Technology Plan Project","award":["22YXYJ0122"],"award-info":[{"award-number":["22YXYJ0122"]}]},{"name":"IIT Clinical Research Fund of The Second Affiliated Hospital of Xi\u2019an Jiaotong University","award":["M074"],"award-info":[{"award-number":["M074"]}]},{"name":"Science and Technology Research Project for Social Development of Shaanxi Province","award":["2015SF145"],"award-info":[{"award-number":["2015SF145"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s11739-025-04173-1","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:05:52Z","timestamp":1761894352000},"page":"163-174","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Risk factors and prediction model for sarcopenia in patients with cirrhosis undergoing transjugular intrahepatic portosystemic shunt"],"prefix":"10.1007","volume":"21","author":[{"given":"Shuyue","family":"Tuo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhang","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuju","family":"Ran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quanxin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinhai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shejiao","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4105-6890","authenticated-orcid":false,"given":"Xinxing","family":"Tantai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,31]]},"reference":[{"issue":"10308","key":"4173_CR1","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/s0140-6736(21)01374-x","volume":"398","author":"P Gin\u00e8s","year":"2021","unstructured":"Gin\u00e8s P, Krag A, Abraldes JG, Sol\u00e0 E, Fabrellas N, Kamath PS (2021) Liver cirrhosis. Lancet 398(10308):1359\u20131376. https:\/\/doi.org\/10.1016\/s0140-6736(21)01374-x","journal-title":"Lancet"},{"issue":"3","key":"4173_CR2","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.jhep.2017.10.020","volume":"68","author":"G D\u2019Amico","year":"2018","unstructured":"D\u2019Amico G, Morabito A, D\u2019Amico M, Pasta L, Malizia G, Rebora P, Valsecchi MG (2018) Clinical states of cirrhosis and competing risks. J Hepatol 68(3):563\u2013576. https:\/\/doi.org\/10.1016\/j.jhep.2017.10.020","journal-title":"J Hepatol"},{"issue":"7","key":"4173_CR3","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/s2468-1253(23)00438-7","volume":"9","author":"S Guix\u00e9-Muntet","year":"2024","unstructured":"Guix\u00e9-Muntet S, Quesada-V\u00e1zquez S, Gracia-Sancho J (2024) Pathophysiology and therapeutic options for cirrhotic portal hypertension. Lancet Gastroenterol Hepatol 9(7):646\u2013663. https:\/\/doi.org\/10.1016\/s2468-1253(23)00438-7","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"40","key":"4173_CR4","doi-asserted-by":"publisher","first-page":"6111","DOI":"10.3748\/wjg.v26.i40.6111","volume":"26","author":"LS Gunarathne","year":"2020","unstructured":"Gunarathne LS, Rajapaksha H, Shackel N, Angus PW, Herath CB (2020) Cirrhotic portal hypertension: from pathophysiology to novel therapeutics. World J Gastroenterol 26(40):6111\u20136140. https:\/\/doi.org\/10.3748\/wjg.v26.i40.6111","journal-title":"World J Gastroenterol"},{"issue":"4","key":"4173_CR5","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.mayocp.2018.12.020","volume":"94","author":"DA Simonetto","year":"2019","unstructured":"Simonetto DA, Liu M, Kamath PS (2019) Portal hypertension and related complications: diagnosis and management. Mayo Clin Proc 94(4):714\u2013726. https:\/\/doi.org\/10.1016\/j.mayocp.2018.12.020","journal-title":"Mayo Clin Proc"},{"issue":"8","key":"4173_CR6","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.jfma.2023.02.007","volume":"122","author":"CH Wu","year":"2023","unstructured":"Wu CH, Ho MC, Kao JH, Ho CM, Su TH, Hsu SJ, Huang HY, Lin CY, Liang PC (2023) Effects of transjugular intrahepatic portosystemic shunt on abdominal muscle mass in patients with decompensated cirrhosis. J Formos Med Assoc 122(8):747\u2013756. https:\/\/doi.org\/10.1016\/j.jfma.2023.02.007","journal-title":"J Formos Med Assoc"},{"key":"4173_CR7","doi-asserted-by":"publisher","first-page":"101617","DOI":"10.1016\/j.arr.2022.101617","volume":"78","author":"C Smith","year":"2022","unstructured":"Smith C, Woessner MN, Sim M, Levinger I (2022) Sarcopenia definition: does it really matter? Implications for resistance training. Ageing Res Rev 78:101617. https:\/\/doi.org\/10.1016\/j.arr.2022.101617","journal-title":"Ageing Res Rev"},{"issue":"Suppl 1","key":"4173_CR8","doi-asserted-by":"publisher","first-page":"S147","DOI":"10.1016\/j.jhep.2021.01.025","volume":"75","author":"P Tandon","year":"2021","unstructured":"Tandon P, Montano-Loza AJ, Lai JC, Dasarathy S, Merli M (2021) Sarcopenia and frailty in decompensated cirrhosis. J Hepatol 75(Suppl 1):S147-s162. https:\/\/doi.org\/10.1016\/j.jhep.2021.01.025","journal-title":"J Hepatol"},{"issue":"3","key":"4173_CR9","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.mcna.2022.12.007","volume":"107","author":"C Bunchorntavakul","year":"2023","unstructured":"Bunchorntavakul C (2023) Sarcopenia and frailty in cirrhosis: assessment and management. Med Clin North Am 107(3):589\u2013604. https:\/\/doi.org\/10.1016\/j.mcna.2022.12.007","journal-title":"Med Clin North Am"},{"issue":"3","key":"4173_CR10","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.jhep.2021.11.006","volume":"76","author":"X Tantai","year":"2022","unstructured":"Tantai X, Liu Y, Yeo YH, Praktiknjo M, Mauro E, Hamaguchi Y, Engelmann C, Zhang P, Jeong JY, van Vugt JLA et al (2022) Effect of sarcopenia on survival in patients with cirrhosis: a meta-analysis. J Hepatol 76(3):588\u2013599. https:\/\/doi.org\/10.1016\/j.jhep.2021.11.006","journal-title":"J Hepatol"},{"issue":"1","key":"4173_CR11","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.clnu.2023.11.008","volume":"43","author":"S Tuo","year":"2024","unstructured":"Tuo S, Yeo YH, Chang R, Wen Z, Ran Q, Yang L, Fan Q, Kang J, Si J, Liu Y et al (2024) Prevalence of and associated factors for sarcopenia in patients with liver cirrhosis: a systematic review and meta-analysis. Clin Nutr 43(1):84\u201394. https:\/\/doi.org\/10.1016\/j.clnu.2023.11.008","journal-title":"Clin Nutr"},{"issue":"6","key":"4173_CR12","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.cgh.2016.10.028","volume":"15","author":"S Nardelli","year":"2017","unstructured":"Nardelli S, Lattanzi B, Torrisi S, Greco F, Farcomeni A, Gioia S, Merli M, Riggio O (2017) Sarcopenia is risk factor for development of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt placement. Clin Gastroenterol Hepatol 15(6):934\u2013936. https:\/\/doi.org\/10.1016\/j.cgh.2016.10.028","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"4173_CR13","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.dld.2024.10.013","volume":"57","author":"E Vanderschueren","year":"2025","unstructured":"Vanderschueren E, Meersseman P, Wilmer A, Vandecaveye V, Dubois E, Van Eldere A, Clerick J, Peluso JP, Claus E, Bonne L et al (2025) Sarcopenia in patients receiving TIPS is independently associated with increased risk of complications and mortality. Dig Liver Dis 57(2):549\u2013557. https:\/\/doi.org\/10.1016\/j.dld.2024.10.013","journal-title":"Dig Liver Dis"},{"issue":"4","key":"4173_CR14","doi-asserted-by":"publisher","first-page":"e00025","DOI":"10.14309\/ctg.0000000000000025","volume":"10","author":"M Praktiknjo","year":"2019","unstructured":"Praktiknjo M, Clees C, Pigliacelli A, Fischer S, Jansen C, Lehmann J, Pohlmann A, Lattanzi B, Krabbe VK, Strassburg CP et al (2019) Sarcopenia is associated with development of acute-on-chronic liver failure in decompensated liver cirrhosis receiving transjugular intrahepatic portosystemic shunt. Clin Transl Gastroenterol 10(4):e00025. https:\/\/doi.org\/10.14309\/ctg.0000000000000025","journal-title":"Clin Transl Gastroenterol"},{"issue":"9","key":"4173_CR15","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1016\/j.dld.2024.03.003","volume":"56","author":"MG Delgado","year":"2024","unstructured":"Delgado MG, Mertineit N, Bosch J, Baumgartner I, Berzigotti A (2024) Combination of model for End-Stage Liver Disease (MELD) and sarcopenia predicts mortality after transjugular intrahepatic portosystemic shunt (TIPS). Dig Liver Dis 56(9):1544\u20131550. https:\/\/doi.org\/10.1016\/j.dld.2024.03.003","journal-title":"Dig Liver Dis"},{"issue":"7","key":"4173_CR16","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.dld.2023.01.001","volume":"55","author":"J Liu","year":"2023","unstructured":"Liu J, Yang C, Yao J, Bai Y, Li T, Wang Y, Shi Q, Wu X, Ma J, Zhou C et al (2023) Improvement of sarcopenia is beneficial for prognosis in cirrhotic patients after TIPS placement. Dig Liver Dis 55(7):918\u2013925. https:\/\/doi.org\/10.1016\/j.dld.2023.01.001","journal-title":"Dig Liver Dis"},{"issue":"7","key":"4173_CR17","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1038\/ctg.2015.31","volume":"6","author":"AJ Montano-Loza","year":"2015","unstructured":"Montano-Loza AJ, Duarte-Rojo A, Meza-Junco J, Baracos VE, Sawyer MB, Pang JX, Beaumont C, Esfandiari N, Myers RP (2015) Inclusion of sarcopenia within MELD (MELD-sarcopenia) and the prediction of mortality in patients with cirrhosis. Clin Transl Gastroenterol 6(7):e102. https:\/\/doi.org\/10.1038\/ctg.2015.31","journal-title":"Clin Transl Gastroenterol"},{"issue":"3","key":"4173_CR18","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1002\/hep.32049","volume":"74","author":"JC Lai","year":"2021","unstructured":"Lai JC, Tandon P, Bernal W, Tapper EB, Ekong U, Dasarathy S, Carey EJ (2021) Malnutrition, frailty, and sarcopenia in patients with cirrhosis: 2021 practice guidance by the American Association for the Study of Liver Diseases. Hepatology 74(3):1611\u20131644. https:\/\/doi.org\/10.1002\/hep.32049","journal-title":"Hepatology"},{"key":"4173_CR19","doi-asserted-by":"publisher","first-page":"g7594","DOI":"10.1136\/bmj.g7594","volume":"350","author":"GS Collins","year":"2015","unstructured":"Collins GS, Reitsma JB, Altman DG, Moons KG (2015) Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMJ 350:g7594. https:\/\/doi.org\/10.1136\/bmj.g7594","journal-title":"BMJ"},{"issue":"3","key":"4173_CR20","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/apha.12224","volume":"210","author":"J Aubrey","year":"2014","unstructured":"Aubrey J, Esfandiari N, Baracos VE, Buteau FA, Frenette J, Putman CT, Mazurak VC (2014) Measurement of skeletal muscle radiation attenuation and basis of its biological variation. Acta Physiol (Oxf) 210(3):489\u2013497. https:\/\/doi.org\/10.1111\/apha.12224","journal-title":"Acta Physiol (Oxf)"},{"issue":"6","key":"4173_CR21","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1002\/jcsm.12797","volume":"12","author":"X Zeng","year":"2021","unstructured":"Zeng X, Shi ZW, Yu JJ, Wang LF, Luo YY, Jin SM, Zhang LY, Tan W, Shi PM, Yu H et al (2021) Sarcopenia as a prognostic predictor of liver cirrhosis: a multicentre study in China. J Cachexia Sarcopenia Muscle 12(6):1948\u20131958. https:\/\/doi.org\/10.1002\/jcsm.12797","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"3","key":"4173_CR22","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3350\/cmh.2017.0077","volume":"24","author":"DH Gu","year":"2018","unstructured":"Gu DH, Kim MY, Seo YS, Kim SG, Lee HA, Kim TH, Jung YK, Kandemir A, Kim JH, An H et al (2018) Clinical usefulness of psoas muscle thickness for the diagnosis of sarcopenia in patients with liver cirrhosis. Clin Mol Hepatol 24(3):319\u2013330. https:\/\/doi.org\/10.3350\/cmh.2017.0077","journal-title":"Clin Mol Hepatol"},{"issue":"6","key":"4173_CR23","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.jhep.2014.02.026","volume":"60","author":"F Durand","year":"2014","unstructured":"Durand F, Buyse S, Francoz C, Laou\u00e9nan C, Bruno O, Belghiti J, Moreau R, Vilgrain V, Valla D (2014) Prognostic value of muscle atrophy in cirrhosis using psoas muscle thickness on computed tomography. J Hepatol 60(6):1151\u20131157. https:\/\/doi.org\/10.1016\/j.jhep.2014.02.026","journal-title":"J Hepatol"},{"key":"4173_CR24","doi-asserted-by":"publisher","first-page":"m441","DOI":"10.1136\/bmj.m441","volume":"368","author":"RD Riley","year":"2020","unstructured":"Riley RD, Ensor J, Snell KIE, Harrell FE Jr, Martin GP, Reitsma JB, Moons KGM, Collins G, van Smeden M (2020) Calculating the sample size required for developing a clinical prediction model. Bmj 368:m441. https:\/\/doi.org\/10.1136\/bmj.m441","journal-title":"Bmj"},{"issue":"1","key":"4173_CR25","doi-asserted-by":"publisher","first-page":"9759","DOI":"10.1038\/s41598-024-60305-1","volume":"14","author":"HR Lin","year":"2024","unstructured":"Lin HR, Liao QX, Lin XX, Zhou Y, Lin JD, Xiao XJ (2024) Development of a nomogram for predicting in-hospital mortality in patients with liver cirrhosis and sepsis. Sci Rep 14(1):9759. https:\/\/doi.org\/10.1038\/s41598-024-60305-1","journal-title":"Sci Rep"},{"issue":"7","key":"4173_CR26","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1002\/hep4.1919","volume":"6","author":"E Mauro","year":"2022","unstructured":"Mauro E, Diaz JM, Garcia-Olveira L, Spina JC, Savluk L, Zalazar F, Saidman J, De Santiba\u00f1es M, Pekolj J, De Santiba\u00f1es E et al (2022) Sarcopenia HIBA score predicts sarcopenia and mortality in patients on the liver transplant waiting list. Hepatol Commun 6(7):1699\u20131710. https:\/\/doi.org\/10.1002\/hep4.1919","journal-title":"Hepatol Commun"},{"issue":"4","key":"4173_CR27","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1080\/01635581.2023.2176199","volume":"75","author":"S Lei","year":"2023","unstructured":"Lei S, Zhang Q, Zhang Q, Long L, Xiong Y, Sun S, Yuan H, Luo Y, Chen N, Peng H et al (2023) The systemic immune inflammation index (SII) combined with the creatinine-to-cystatin C ratio (Cre\/CysC) predicts sarcopenia in patients with liver cirrhosis complicated with primary hepatocellular carcinoma. Nutr Cancer 75(4):1116\u20131122. https:\/\/doi.org\/10.1080\/01635581.2023.2176199","journal-title":"Nutr Cancer"},{"issue":"3","key":"4173_CR28","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1002\/jcsm.12977","volume":"13","author":"T Tang","year":"2022","unstructured":"Tang T, Xie L, Hu S, Tan L, Lei X, Luo X, Yang L, Yang M (2022) Serum creatinine and cystatin c-based diagnostic indices for sarcopenia in advanced non-small cell lung cancer. J Cachexia Sarcopenia Muscle 13(3):1800\u20131810. https:\/\/doi.org\/10.1002\/jcsm.12977","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"4173_CR29","doi-asserted-by":"publisher","first-page":"155533","DOI":"10.1016\/j.metabol.2023.155533","volume":"144","author":"S Yuan","year":"2023","unstructured":"Yuan S, Larsson SC (2023) Epidemiology of sarcopenia: Prevalence, risk factors, and consequences. Metabolism 144:155533. https:\/\/doi.org\/10.1016\/j.metabol.2023.155533","journal-title":"Metabolism"},{"key":"4173_CR30","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s41232-016-0022-5","volume":"36","author":"S Ogawa","year":"2016","unstructured":"Ogawa S, Yakabe M, Akishita M (2016) Age-related sarcopenia and its pathophysiological bases. Inflamm Regen 36:17. https:\/\/doi.org\/10.1186\/s41232-016-0022-5","journal-title":"Inflamm Regen"},{"issue":"8","key":"4173_CR31","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.dld.2021.10.010","volume":"54","author":"M Guarino","year":"2022","unstructured":"Guarino M, Cossiga V, Becchetti C, Invernizzi F, Lapenna L, Lavezzo B, Lenci I, Merli M, Pasulo L, Zanetto A et al (2022) Sarcopenia in chronic advanced liver diseases: a sex-oriented analysis of the literature. Dig Liver Dis 54(8):997\u20131006. https:\/\/doi.org\/10.1016\/j.dld.2021.10.010","journal-title":"Dig Liver Dis"},{"issue":"6","key":"4173_CR32","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.1002\/jcsm.13059","volume":"13","author":"R Lowe","year":"2022","unstructured":"Lowe R, Hey P, Sinclair M (2022) The sex-specific prognostic utility of sarcopenia in cirrhosis. J Cachexia Sarcopenia Muscle 13(6):2608\u20132615. https:\/\/doi.org\/10.1002\/jcsm.13059","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"4","key":"4173_CR33","doi-asserted-by":"publisher","first-page":"615","DOI":"10.5604\/01.3001.0012.0930","volume":"17","author":"C Moctezuma-Vel\u00e1zquez","year":"2018","unstructured":"Moctezuma-Vel\u00e1zquez C, Low G, Mourtzakis M, Ma M, Burak KW, Tandon P, Montano-Loza AJ (2018) Association between low testosterone levels and sarcopenia in cirrhosis: a cross-sectional study. Ann Hepatol 17(4):615\u2013623. https:\/\/doi.org\/10.5604\/01.3001.0012.0930","journal-title":"Ann Hepatol"},{"issue":"5","key":"4173_CR34","doi-asserted-by":"publisher","first-page":"100723","DOI":"10.1016\/j.aohep.2022.100723","volume":"27","author":"M Hern\u00e1ndez-Conde","year":"2022","unstructured":"Hern\u00e1ndez-Conde M, Llop E, G\u00f3mez-Pimpollo L, Blanco S, Rodr\u00edguez L, Fern\u00e1ndez Carrillo C, Perell\u00f3 C, L\u00f3pez-G\u00f3mez M, Mart\u00ednez-Porras JL, Fern\u00e1ndez-Puga N et al (2022) A nomogram as an indirect method to identify sarcopenia in patients with liver cirrhosis. Ann Hepatol 27(5):100723. https:\/\/doi.org\/10.1016\/j.aohep.2022.100723","journal-title":"Ann Hepatol"},{"issue":"2","key":"4173_CR35","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/jdi.12908","volume":"10","author":"Y Fukuoka","year":"2019","unstructured":"Fukuoka Y, Narita T, Fujita H, Morii T, Sato T, Sassa MH, Yamada Y (2019) Importance of physical evaluation using skeletal muscle mass index and body fat percentage to prevent sarcopenia in elderly Japanese diabetes patients. J Diabetes Investig 10(2):322\u2013330. https:\/\/doi.org\/10.1111\/jdi.12908","journal-title":"J Diabetes Investig"},{"issue":"4","key":"4173_CR36","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1007\/s10620-022-07806-z","volume":"68","author":"T Li","year":"2023","unstructured":"Li T, Liu J, Zhao J, Bai Y, Huang S, Yang C, Wang Y, Zhou C, Wang C, Ju S et al (2023) Sarcopenia defined by psoas muscle thickness predicts mortality after transjugular intrahepatic portosystemic shunt. Dig Dis Sci 68(4):1641\u20131652. https:\/\/doi.org\/10.1007\/s10620-022-07806-z","journal-title":"Dig Dis Sci"},{"issue":"12","key":"4173_CR37","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1111\/liv.14217","volume":"39","author":"R Paternostro","year":"2019","unstructured":"Paternostro R, Lampichler K, Bardach C, Asenbaum U, Landler C, Bauer D, Mandorfer M, Schwarzer R, Trauner M, Reiberger T et al (2019) The value of different CT-based methods for diagnosing low muscle mass and predicting mortality in patients with cirrhosis. Liver Int 39(12):2374\u20132385. https:\/\/doi.org\/10.1111\/liv.14217","journal-title":"Liver Int"},{"issue":"12","key":"4173_CR38","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1007\/s00535-024-02154-3","volume":"59","author":"IL Kunzler","year":"2024","unstructured":"Kunzler IL, Da Croce MA, Fornari F (2024) Alcohol-associated liver disease increases the risk of muscle loss and mortality in patients with cirrhosis. J Gastroenterol 59(12):1143. https:\/\/doi.org\/10.1007\/s00535-024-02154-3","journal-title":"J Gastroenterol"},{"issue":"14","key":"4173_CR39","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.3748\/wjg.v28.i14.1430","volume":"28","author":"N Pugliese","year":"2022","unstructured":"Pugliese N, Arcari I, Aghemo A, Lania AG, Lleo A, Mazziotti G (2022) Osteosarcopenia in autoimmune cholestatic liver diseases: causes, management, and challenges. World J Gastroenterol 28(14):1430\u20131443. https:\/\/doi.org\/10.3748\/wjg.v28.i14.1430","journal-title":"World J Gastroenterol"},{"key":"4173_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21165678","author":"HJ An","year":"2020","unstructured":"An HJ, Tizaoui K, Terrazzino S, Cargnin S, Lee KH, Nam SW, Kim JS, Yang JW, Lee JY, Smith L et al (2020) Sarcopenia in autoimmune and rheumatic diseases: a comprehensive review. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21165678","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4173_CR41","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/apt.15571","volume":"51","author":"C Bunchorntavakul","year":"2020","unstructured":"Bunchorntavakul C, Reddy KR (2020) Review article: malnutrition\/sarcopenia and frailty in patients with cirrhosis. Aliment Pharmacol Ther 51(1):64\u201377. https:\/\/doi.org\/10.1111\/apt.15571","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"4173_CR42","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1002\/poh2.70006","volume":"4","author":"B Cui","year":"2025","unstructured":"Cui B, Yang Z, Sun C (2025) The prognostic significance of handgrip strength in cirrhosis: simplicity is the ultimate sophistication. Portal Hypertens Cirrhosis 4(2):100\u2013110. https:\/\/doi.org\/10.1002\/poh2.70006","journal-title":"Portal Hypertens Cirrhosis"},{"issue":"8","key":"4173_CR43","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.cgh.2016.03.036","volume":"14","author":"ES Orman","year":"2016","unstructured":"Orman ES, Ghabril M, Chalasani N (2016) Poor Performance Status Is Associated With Increased Mortality in Patients With Cirrhosis. Clin Gastroenterol Hepatol 14(8):1189-1195.e1181. https:\/\/doi.org\/10.1016\/j.cgh.2016.03.036","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"4173_CR44","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jamda.2019.12.012","volume":"21","author":"LK Chen","year":"2020","unstructured":"Chen LK, Woo J, Assantachai P, Auyeung TW, Chou MY, Iijima K, Jang HC, Kang L, Kim M, Kim S et al (2020) Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. J Am Med Dir Assoc 21(3):300-307.e302. https:\/\/doi.org\/10.1016\/j.jamda.2019.12.012","journal-title":"J Am Med Dir Assoc"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-025-04173-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11739-025-04173-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-025-04173-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T14:01:47Z","timestamp":1772200907000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11739-025-04173-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["4173"],"URL":"https:\/\/doi.org\/10.1007\/s11739-025-04173-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7311054\/v1","asserted-by":"object"}]},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"assertion":[{"value":"13 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors do not have conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol received official approval from the Ethical Committee of our hospital (No. 2022032), and individual patient consent was waived due to the retrospective nature of the analysis.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}